Skip to main content
. Author manuscript; available in PMC: 2018 Sep 24.
Published in final edited form as: AIDS. 2017 Sep 24;31(15):2135–2145. doi: 10.1097/QAD.0000000000001586

Fig. 3. Budget impact analysis over 10 years for rural and urban settings.

Fig. 3

Budget impact analysis over a 10-year time horizon for the rural (CLIN and POC-CD412) and urban (LAB-CD46, POC-CD46, and VL12) settings. Cumulative costs (2014 US$, millions) are on the vertical axis and include: clinical care (gray), 1st-line ART (gold), 2nd-line ART (blue), and monitoring costs (orange). Projected life expectancy for each strategy are shown in life years above each column. US$, US dollars; CLIN, clinical; POC, point-of-care; LAB, laboratory; VL, viral load; ART, antiretroviral therapy.